Paper34513635
Foot and Mouth Disease Vaccine Development and Challenges in Inducing Long-Lasting Immunity: Trends and Current Perspectives.
Kenubih A. Vet Med (Auckl), 2021. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Foot and Mouth Disease Vaccine Development and Challenges in Inducing Long-Lasting Immunity: Trends and Current Perspectives. Papers, record 34513635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34513635
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Foot and Mouth Disease Vaccine Development and Challenges in Inducing Long-Lasting Immunity: Trends and Current Perspectives.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2835508 | Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. | J Virol | 1988 | https://conductscience.org/library/papers/2835508 | PubMed |
| 2 | 12527439 | FMD vaccines. | Virus Res | 2003 | https://conductscience.org/library/papers/12527439 | PubMed |
| 3 | 18829763 | Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines. | J Virol | 2008 | https://conductscience.org/library/papers/18829763 | PubMed |
| 4 | 31562676 | Comparison of chemical extraction methods for determination of 146S content in foot-and-mouth disease oil-adjuvanted vaccine. | J Appl Microbiol | 2020 | https://conductscience.org/library/papers/31562676 | PubMed |
| 5 | 2411948 | Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells. | J Virol | 1985 | https://conductscience.org/library/papers/2411948 | PubMed |
| 6 | 12885881 | Identification of foot-and-mouth disease virus-specific linear B-cell epitopes to differentiate between infected and vaccinated cattle. | J Virol | 2003 | https://conductscience.org/library/papers/12885881 | PubMed |
| 7 | 21177918 | Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination. | Clin Vaccine Immunol | 2011 | https://conductscience.org/library/papers/21177918 | PubMed |
| 8 | 16973584 | Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. | J Virol | 2006 | https://conductscience.org/library/papers/16973584 | PubMed |
| 9 | 18448534 | Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response. | J Virol | 2008 | https://conductscience.org/library/papers/18448534 | PubMed |
| 10 | 14585679 | Immune response in mice inoculated with plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus. | Vaccine | 2003 | https://conductscience.org/library/papers/14585679 | PubMed |
| 11 | 28619144 | Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle. | Vet Microbiol | 2017 | https://conductscience.org/library/papers/28619144 | PubMed |
| 12 | 16823927 | Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus. | Vaccine | 2006 | https://conductscience.org/library/papers/16823927 | PubMed |
| 13 | 22591597 | Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics. | BMC Vet Res | 2012 | https://conductscience.org/library/papers/22591597 | PubMed |
| 14 | 16522345 | Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. | Vaccine | 2006 | https://conductscience.org/library/papers/16522345 | PubMed |
| 15 | 34066901 | Peptide-Based Vaccines: Foot-and-Mouth Disease Virus, a Paradigm in Animal Health. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34066901 | PubMed |
| 16 | 17913861 | Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease. | Clin Vaccine Immunol | 2007 | https://conductscience.org/library/papers/17913861 | PubMed |
| 17 | 15811646 | Interleukin-2 potentiates foot-and-mouth disease vaccinal immune responses in mice. | Vaccine | 2005 | https://conductscience.org/library/papers/15811646 | PubMed |
| 18 | 21307187 | Bovine plasmacytoid dendritic cells are the major source of type I interferon in response to foot-and-mouth disease virus in vitro and in vivo. | J Virol | 2011 | https://conductscience.org/library/papers/21307187 | PubMed |
| 19 | 17427949 | Induction of immature dendritic cell apoptosis by foot and mouth disease virus is an integrin receptor mediated event before viral infection. | J Cell Biochem | 2007 | https://conductscience.org/library/papers/17427949 | PubMed |
| 20 | 19211755 | Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine. | J Virol | 2009 | https://conductscience.org/library/papers/19211755 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974939 | Seroprevalence and Risk Factors Analysis of Foot-and-Mouth Disease in Cattle and Buffaloes in Punjab of Pakistan: A 3ABC ELISA-Based Study. | Transbound Emerg Dis | 2026 | https://conductscience.org/library/papers/42974939 | PubMed |
| 42751309 | Immunostimulant-integrated acrylate nanocomposite adjuvants potentiate foot-and-mouth disease vaccine efficacy. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42751309 | PubMed |
| 42265219 | Immunoinformatics-based design of artificial chimeric proteins as universal vaccine candidates against foot-and-mouth disease virus serotypes A, O, and SAT2. | Sci Rep | 2026 | https://conductscience.org/library/papers/42265219 | PubMed |
| 42188829 | Immunogenicity of Theileria parva p67C Antigen Delivered via Adjuvanted CoPoP Liposomes in Cattle and Mice. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188829 | PubMed |
| 41727332 | Plant-Based Recombinant Vaccines for Foot-and-Mouth Disease: A Meta-Synthesis. | Avicenna J Med Biotechnol | 2025 | https://conductscience.org/library/papers/41727332 | PubMed |
| 41716171 | Chitosan nanoparticles as next-generation carriers for veterinary DNA vaccines: Mechanisms, immune responses, and translational prospects. | Vet World | 2025 | https://conductscience.org/library/papers/41716171 | PubMed |
| 41455997 | Phylogenetic and evolutionary analysis of VP1 coding sequences of foot-and-mouth disease virus serotypes A, O, and SAT2 in Egypt. | Virol J | 2025 | https://conductscience.org/library/papers/41455997 | PubMed |
| 41214185 | Systematic review and meta-analysis of the effectiveness of polypeptide, virus-like particles, and viral vector vaccines for foot-and-mouth disease (2020-2025). | Sci Rep | 2025 | https://conductscience.org/library/papers/41214185 | PubMed |
| 41113204 | Optimizing formaldehyde and binary ethylenimine combinations for inactivation of foot-and-mouth disease virus GR12: insights from Indonesia's third outbreak for local vaccine development. | Vet World | 2025 | https://conductscience.org/library/papers/41113204 | PubMed |
| 41025158 | Development and immunogenicity of adenoviral Fc-fused FMDV virus-like particle vaccine in swine. | Vet Q | 2025 | https://conductscience.org/library/papers/41025158 | PubMed |
| 40740301 | Advancements in antiviral approaches against foot-and-mouth disease virus: a comprehensive review. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/40740301 | PubMed |
| 40559776 | Foot-and-Mouth Disease Virus-like Particles Produced in E. coli as Potential Antigens for a Novel Vaccine. | Vet Sci | 2025 | https://conductscience.org/library/papers/40559776 | PubMed |
| 40557100 | Current trends and challenges in the management of foot and mouth disease in Saudi Arabia: A review. | Open Vet J | 2025 | https://conductscience.org/library/papers/40557100 | PubMed |
| 40356647 | Preliminary evaluation of a novel serotype O foot-and-mouth disease mRNA vaccine. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40356647 | PubMed |
| 40197411 | Foot-and-mouth disease: genomic and proteomic structure, antigenic sites, serotype relationships, immune evasion, recent vaccine development strategies, and future perspectives. | Vet Res | 2025 | https://conductscience.org/library/papers/40197411 | PubMed |
| 40055785 | A novel immunoinformatic approach for design and evaluation of heptavalent multiepitope foot-and-mouth disease virus vaccine. | BMC Vet Res | 2025 | https://conductscience.org/library/papers/40055785 | PubMed |
| 39328437 | Protein characterization of an Indonesian isolate of foot and mouth disease virus inactivated with formaldehyde and binary ethylenimine. | Vet World | 2024 | https://conductscience.org/library/papers/39328437 | PubMed |
| 38793727 | Evaluation of Swine Protection with Three Commercial Foot-and-Mouth Disease Vaccines against Heterologous Challenge with Type A ASIA/G-VII Lineage Viruses. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38793727 | PubMed |
| 38029108 | Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease. | Front Microbiol | 2023 | https://conductscience.org/library/papers/38029108 | PubMed |
| 37983290 | Conserved antigen structures and antibody-driven variations on foot-and-mouth disease virus serotype A revealed by bovine neutralizing monoclonal antibodies. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37983290 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EXOSC4 | 54512 | PubTator's text mining | https://conductscience.org/library/genes/54512 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34513635
GET https://conductscience.org/api/papers/v1/34513635/references?page=2